Mark Currie
Director/Board Member bei IRONWOOD PHARMACEUTICALS, INC.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Mark G.
Currie is currently an Independent Director at Ironwood Pharmaceuticals, Inc., a Director at Science Exchange, Inc., and a Director at Sea Pharmaceuticals LLC.
He previously worked as a Director of Arthritis & Inflammation at Monsanto Co. and G.D.
Searle & Co., Inc. He was also the Vice President of Discovery Research at Sumitomo Pharma America, Inc. from 1999 to 2002.
From 2002 to 2019, he worked at Ironwood Pharmaceuticals, Inc. as the Chief Scientific Officer, President-R&D, and Senior VP.
He was the President & Chief Scientific Officer at Cyclerion Therapeutics, Inc. from 2019 to 2020.
Dr. Currie holds a doctorate degree from Wake Forest School of Medicine and an undergraduate degree from the University of South Alabama.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.06.2023 | 544 108 ( 0,35% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Mark Currie
| Unternehmen | Position | Beginn |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 01.01.2020 |
Science Exchange, Inc.
 Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Director/Board Member | 12.02.2020 |
Sea Pharmaceuticals LLC
 Sea Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sea Pharmaceuticals LLC manufactures and markets pharmaceutical products and services. The company is headquartered in Cambridge, MA. | Director/Board Member | 01.02.2021 |
Ehemalige bekannte Positionen von Mark Currie
| Unternehmen | Position | Ende |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | President | 01.12.2020 |
| IRONWOOD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.03.2019 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01.08.2002 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | - |
| MONSANTO | Corporate Officer/Principal | - |
Ausbildung von Mark Currie
| Wake Forest School of Medicine | Doctorate Degree |
| University of South Alabama | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Science Exchange, Inc.
Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Technology Services |
Sea Pharmaceuticals LLC
Sea Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sea Pharmaceuticals LLC manufactures and markets pharmaceutical products and services. The company is headquartered in Cambridge, MA. | Health Technology |
